ArticleMolecular and cellular biochemistry2022

TRG16, targeted by miR-765, inhibits breast cancer stem cell-like properties via regulating the NF-κB pathway.

Feng Chi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.